{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cytochrome P450", "herb-drug interactions", "plant medicine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30392393", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2019", "Month": "03", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["2515690X18810001", "10.1177/2515690X18810001"], "Journal": {"ISSN": "2515-690X", "JournalIssue": {"Volume": "23", "PubDate": {"Year": "2018", "Season": "Jan-Dec"}}, "Title": "Journal of evidence-based integrative medicine", "ISOAbbreviation": "J Evid Based Integr Med"}, "ArticleTitle": "In Vivo Modulation of Rat Liver Microsomal Cytochrome P450 Activity by Antimalarial, Anti-HIV, and Antituberculosis Plant Medicines.", "Pagination": {"StartPage": "2515690X18810001", "MedlinePgn": "2515690X18810001"}, "Abstract": {"AbstractText": ["Drug interactions are key reasons for adverse drug reactions and attrition from market. Major infectious diseases causing morbidity/mortality in Ghana are malaria, tuberculosis, and HIV/AIDS. In this study, plant medicines commonly used to treat/manage these diseases in Ghana were investigated for their potential to modulate rat cytochrome P450 enzyme activities. Fluorescence and high-performance liquid chromatography-based assays were used to assess effects of antimalarial plant medicines, Fever (FEV), Mal-TF (MAL), and Kantinka terric (KT); anti-TB medicines, Chestico (CHES), CA + ST Pains + HWNT (TF), and Kantinka herbatic (KHB); and anti-HIV/AIDS medicines, Wabco (WAB), AD + T/AD (LIV) and Kantinka BA (KBA) on rat liver microsomal cytochrome P450 enzyme activities. Effects of medicines on rat biochemical and hematological parameters were also assessed. Generally, the medicines altered microsomal CYP1A1/1A2, CYP2B1/2B2, CYP2C9, and CYP2D6 activities. Only KBA elicited an increase (80%) in CYP1A1/1A2 activity. FEV, MAL, CHES, WAB, and LIV strongly inhibited the enzyme activity. All the medicines significantly inhibited CYP2C9 (24%-80%) activity. CYP2D6 activity increased after treatment with MAL, KBA, LIV, and TF. Also, MAL, WAB, LIV, KHB, and CHES increased CYP2B1/2B2 activity, while KT decrease the activity. Generally, the medicines altered liver function in the rats. Cholesterol levels declined after KBA treatment only. White and red blood cell counts, hemoglobin and hematocrit levels were significantly reduced in KT- and KBA-treated rats. Our results suggest that use of the medicines could have implications for drug interactions and safety, particularly if the medicines are administered over prolonged periods. Further investigations are imperative to establish clinical relevance of these results."]}, "AuthorList": [{"Identifier": ["0000-0003-4219-7107"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Appiah-Opong", "ForeName": "Regina", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Tuffour", "ForeName": "Isaac", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Ofori-Attah", "ForeName": "Ebenezer", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Aning", "ForeName": "Abigail", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Atchoglo", "ForeName": "Philip", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Danso", "ForeName": "Eunice Ampem", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Ahedor", "ForeName": "Believe", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Adjei", "ForeName": "Samuel", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 University of Ghana, Legon, Ghana."}], "LastName": "Nyarko", "ForeName": "Alexander K", "Initials": "AK"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Evid Based Integr Med", "NlmUniqueID": "101719675", "ISSNLinking": "2515-690X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-HIV Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytochrome P-450 Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "9035-51-2", "NameOfSubstance": "Cytochrome P-450 Enzyme System"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Anti-HIV Agents"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Cytochrome P-450 Enzyme Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytochrome P-450 Enzyme System"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "HIV Infections"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Malaria"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Microsomes, Liver"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Tuberculosis"}], "CoiStatement": "<b>Declaration of Conflicting Interests:</b> The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zlokarnik G, Grootenhuis PDJ, Watson JB. High throughput P450 inhibition screens in early drug discovery. Drug Discov Today. 2005;10:1443\u20131450.", "ArticleIdList": ["16243264"]}, {"Citation": "Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom J. 2005;5:6\u201313.", "ArticleIdList": ["15492763"]}, {"Citation": "Ai N, Fan X, Ekins S. In silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond. Adv Drug Deliv Rev. 2015;86:46\u201360. doi:10.1016/j.addr.2015.03.006", "ArticleIdList": ["25796619"]}, {"Citation": "Martin J, Fay M. Cytochrome P450 drug interactions: are they clinically relevant? Aust Prescr. 2001;24:10\u201312."}, {"Citation": "Zhang ZY, Wong YN. Enzyme kinetics for clinically relevant CYP inhibition. Curr Drug Metab. 2005;6:241\u2013257.", "ArticleIdList": ["15975042"]}, {"Citation": "Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrator of pharmacokinetic drug interactions. Planta Med. 2012;78:1458\u20131477.", "ArticleIdList": ["22855269"]}, {"Citation": "Choi YH, Chin YW, Kim YG. Herb-drug interactions: focus on metabolic enzymes and transporters. Arch Pharm Res. 2011;34:1843\u20131863.", "ArticleIdList": ["22139685"]}, {"Citation": "Cho HJ, Yoon IS. Pharmacokinetic interactions of herbs with cytochrome P450 and P-glycoprotein. Evid Based Complement Alternat Med. 2015;2015:736431 doi:10.1155/2015/736431", "ArticleIdList": ["PMC4302358", "25632290"]}, {"Citation": "Eisenberg DM, Davis R, Ettner S, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569\u20131575.", "ArticleIdList": ["9820257"]}, {"Citation": "Komoroski BJ, Zhang S, Cai H, et al. Induction and inhibition of cytochromes P450 by the St John\u2019s wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos. 2004;32:512\u2013518.", "ArticleIdList": ["15100173"]}, {"Citation": "Oetari S, Sudibyo M, Commandeur JNM, Samhoedi R, Vermeulen NPE. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol. 1996;51:39\u201345.", "ArticleIdList": ["8534266"]}, {"Citation": "Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u2013254.", "ArticleIdList": ["942051"]}, {"Citation": "Appiah-Opong R, Commandeur JNM, van Vugt-Lussenburg B, Vermeulen NPE. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology. 2007;235:83\u201391.", "ArticleIdList": ["17433521"]}, {"Citation": "Yi S, Cho JY, Lim KS, et al. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers. Basic Clin Pharmacol Toxicol. 2009;105:248\u2013256.", "ArticleIdList": ["19422358"]}, {"Citation": "Appiah-Opong R, Commandeur JNM, Axson C, Vermeulen NPE. Interactions between cytochromes P450 and glutathione S-transferases and Ghanaian medicinal plants. Food Chem Toxicol. 2008;46:3598\u20133603.", "ArticleIdList": ["18822337"]}, {"Citation": "Mazzari ALDA, Prieto JM. Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions. Front Pharmacol. 2015;5:162.", "ArticleIdList": ["PMC4087670", "25071580"]}, {"Citation": "Chen XW, Serag ES, Sneed KB, et al. Clinical herbal interactions with conventional drugs: from molecules to maladies. Curr Med Chem. 2011;18:4836\u20134850.", "ArticleIdList": ["21919844"]}, {"Citation": "Amacher DE. The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in preclinical safety studies. Toxicol Mech Methods. 2010;20:159\u2013166.", "ArticleIdList": ["20218941"]}, {"Citation": "Rodeiro I, Gomez-Lechon MJ, Perez G, et al. Mangifera indica L extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes. Phytother Res. 2013;27:745\u2013752.", "ArticleIdList": ["22815239"]}, {"Citation": "Guengerich FP. Cytochromes P450, drugs, and diseases. Mol Interv. 2003;3:194\u2013204.", "ArticleIdList": ["14993447"]}, {"Citation": "Yan Z, Li J, Huebert N, Caldwell GW, Du Y, Zhong H. Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides. Drug Metab Dispos. 2005;33:706\u2013713.", "ArticleIdList": ["15764717"]}, {"Citation": "Koul A, Ghara AR, Gangar SC. Chemomodulatory effects of Azadirachta indica on the hepatic status of skin tumor bearing mice. Phytother Res. 2006;20:169\u2013177.", "ArticleIdList": ["16521106"]}, {"Citation": "Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities and impact of genetic variation. Pharmacol Ther. 2013;138:103\u2013141.", "ArticleIdList": ["23333322"]}, {"Citation": "Inoue T, Nitta K, Sugihara K, Horie T, Kitamura S, Ohta S. CYP2C9-catalyzed metabolism of S-warfarin to 7-hydroxywarfarin in vivo and in vitro in chimeric mice with humanized liver. Drug Metab Dispos. 2008;36:2429\u20132433.", "ArticleIdList": ["18784266"]}, {"Citation": "Marcsisin SR, Reichard G, Pybus BS. Primaquine pharmacology in the context of CYP2D6 pharmacogenetics: current state of the art. Pharmacol Ther. 2016;161:1\u201310.", "ArticleIdList": ["27016470"]}, {"Citation": "Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol. 2008;14:6774\u20136785.", "ArticleIdList": ["PMC2773872", "19058303"]}, {"Citation": "Chalasani N, Fontana RJ, Bonkovsky HL, et al. ; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924\u20131934.e1-e4.", "ArticleIdList": ["PMC3654244", "18955056"]}, {"Citation": "Fevery J. Bilirubin in clinical practice: a review. Liver Int. 2008;28:592\u2013605. doi:10.1111/j.1478-3231.2008.01716.x", "ArticleIdList": ["18433389"]}, {"Citation": "Lushchak VI. Glutathione Homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012;2012:736837. doi:10.1155/2012/736837", "ArticleIdList": ["PMC3303626", "22500213"]}, {"Citation": "Leoni V, Caccia C. The impairment of cholesterol metabolism in Huntington disease. Biochim Biophy Acta. 2015;1851:1095\u20131105. doi:10.1016/j.bbalip.2014.12.018", "ArticleIdList": ["25596342"]}, {"Citation": "Yavad R, France M, Younis N, Hama S, Ammori BJ, Kwok S. Extended release of niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opin Pharmacother. 2012;13:1345\u20131362.", "ArticleIdList": ["22607011"]}, {"Citation": "El-Hazmi MA, Warsy AS. Evaluation of serum cholesterol and triglyceride levels in 1-6-year old Saudi children. J Trop Pediat. 2001;47:181\u2013185.", "ArticleIdList": ["11419685"]}, {"Citation": "Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011;13:544\u2013552.", "ArticleIdList": ["PMC3234107", "21968696"]}, {"Citation": "Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AK, Vernekar SN. Markers of renal function tests. N Am J Med Sci. 2010;2:170\u2013173.", "ArticleIdList": ["PMC3354405", "22624135"]}, {"Citation": "Frandson RD, Wilke WL, Fails AD. Anatomy and Physiology of Farm Animals. 7th ed Hoboken, NJ: Wiley-Blackwell; 2003."}, {"Citation": "Ajeigbe KO, Enitan SS, Omotoso DR, Oladokun OO. Acute effects of aqueous leaf extract of Aspilia Africana C D Adams on some haematological parameters in rats. Afr J Tradit Complement Altern Med. 2013;10:236\u2013243.", "ArticleIdList": ["PMC3847411", "24311831"]}]}], "History": [{"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30392393", "PMC6238197", "10.1177/2515690X18810001"]}}]}